G. E. STOKKER

In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.

S. Vickers, C A Duncan, Kamlesh P. Vyas et al. · Drug Metabolism and Disposition · 1990 · 154 citations

Life Sciences, Biochemistry, Pharmacology +13

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. I. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives

G. E. STOKKER, William F. Hoffman, Alfred W. Alberts et al. · Journal of Medicinal Chemistry · 1985 · 109 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

2-(Aminomethyl)phenols, a new class of saluretic agents. 5. Fused-ring analogs

A. A. Deana, G. E. STOKKER, Everett M. Schultz et al. · Journal of Medicinal Chemistry · 1983 · 87 citations

Pharmacy, Medicinal Chemistry, Pharmacology +5

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted-[1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives

G. E. STOKKER, Alfred W. Alberts, Paul Anderson et al. · Journal of Medicinal Chemistry · 1986 · 68 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +16

Agents for the treatment of brain edema. 2. [(2,3,9,9a-Tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]alkanoic acids and some of their analogs

Edward J. Cragoe, Otto W. Woltersdorf, N. P. GOULD et al. · Journal of Medicinal Chemistry · 1986 · 61 citations

Medicine, Medicinal Chemistry, Pharmacology +17